Skip to main content

Perlegen Wins $420,000 NCI Grant to Study Genetics of Colorectal Cancer with Johns Hopkins

NEW YORK, Feb. 23 (GenomeWeb News) - Perlegen Sciences has won a grant from the National Cancer Institute to study DNA mutations involved in colorectal cancer, in collaboration with researchers at Johns Hopkins University, the company said today.


The grant, worth $420,000 and awarded to Perlegen in fiscal year 2004, according to an NIH database, is entitled "Comprehensive Mutational Analysis of the Cancer Genome." Perlegen scientists, led by Andrew Sparks, the company's director of association studies, plan to analyze thousands of genes in colorectal tumor samples at single-base resolution and compare them to the same genes in normal tissue from the same patients. The aim is to find tumor-specific mutations.


Perlegen will work with scientists at the SidneyKimmelComprehensiveCancerCenterat Johns Hopkins for this project.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.